— Know what they know.
Not Investment Advice

NUWE NASDAQ

Nuwellis, Inc.
1W: -32.3% 1M: -41.5% 3M: +66.4% YTD: +6.6% 1Y: -84.1% 3Y: -99.9% 5Y: -100.0%
$1.93
-0.06 (-3.02%)
 
Weekly Expected Move ±16.7%
$1 $2 $2 $2 $3
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Sell · Power 39 · $703089 mcap · 363213 float · 32.29% daily turnover · Short 48% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.7M
52W Range1.83-392.7
Volume57,147
Avg Volume117,297
Beta0.30
Dividend
Analyst Ratings
1 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOMichael McCormick
Employees38
SectorHealthcare
IndustryMedical - Devices
IPO Date2012-02-16
12988 Valley View Road
Eden Prairie, MN 55344
US
952 345 4200
About Nuwellis, Inc.

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Recent Insider Trades

NameTypeSharesPriceDate
McCormick Michael Ke 0 2026-06-30
WALLER GREGORY D A-Award 6,744 $1.16 2026-04-28
Emerson Martin J A-Award 6,744 $1.16 2026-04-28
Feldshon Archelle Ge A-Award 6,744 $1.16 2026-04-28
McDonald David A-Award 6,744 $1.16 2026-04-28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms